Displaying 10 out of 16 results

  1. Ep 2
    Media playtime

    The Vaccine Quest: Part Two

    The Duke-NUS team is closer to producing a viable vaccine. But creating a viable vaccine is just the first step; producing enough for everyone is ...
  2. New Content Item
    Media playtime

    The Vaccine Quest: Part One

    A Singapore-based team has spent the last year developing a COVID-19 vaccine. How close are they to producing one?
  3. FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli L

    US hospitals to restrict Lilly COVID-19 antibody treatment due to limited supply

    U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co antibody drug to COVID-19 patients ...
  4. Fauci, Redfield testify at U.S. Senate hearing on coronavirus response in Washington

    Fauci says 'reasonably good chance' Regeneron antibody therapy helped Trump

    Top U.S. infectious diseases expert Dr. Anthony Fauci said on Thursday that President Donald Trump's health was likely helped by an experimental ...
  5. FILE PHOTO: Workers clean windows of a building of Roche in Rotkreuz

    Roche, Regeneron link up to develop COVID-19 antibody cocktail

    Regeneron and Roche said on Wednesday they will collaborate on an investigational antibody cocktail against COVID-19, with the U.S. company to ...
  6. Spread of the coronavirus disease (COVID-19) in Burela

    Spanish antibody study shows 5% of population exposed to coronavirus

    Results from the final stage of a nationwide antibody study show about 5.2 per cent of Spain's population has been exposed to the new coronavirus, ...
  7. FILE PHOTO: NHS staff at antibody testing hub run by the West Midlands Ambulance service

    Many studies of COVID-19 antibody test accuracy fall short: Review

    Many studies assessing the accuracy of COVID-19 antibody tests had major shortcomings, a review released on Thursday concluded, offering further ...